Kwang-Suk Lim

Title: Kwang-Suk Lim: Innovator in Gene Delivery Systems

Introduction

Kwang-Suk Lim is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of gene delivery systems, particularly in targeting adipocytes and improving systemic circulation of short interference RNA (siRNA). With a total of 2 patents, his work is paving the way for advancements in obesity treatment and gene therapy.

Latest Patents

One of his latest patents is the "Adipocyte-targeting non-viral gene delivery system." This invention focuses on a gene delivery system designed to target adipocytes directly, offering a novel approach to treating obesity and related metabolic syndromes. The system utilizes an adipocyte targeting sequence (ATS)-arginine (R9) peptide to enhance its effectiveness.

Another significant patent is the "Short interference RNA gene delivery system for systemic circulation." This invention aims to improve the delivery of siRNA and its efficiency in systemic circulation. It is based on polyethylene glycol (PEG) and an arginine 9 (R9) peptide, showcasing innovative methods in gene therapy.

Career Highlights

Kwang-Suk Lim has worked with the Industry-University Cooperation Foundation at Hanyang University, where he has contributed to various research initiatives. His expertise in gene delivery systems has positioned him as a key figure in the field.

Collaborations

He has collaborated with notable colleagues, including Yong-Hee Kim and Hyun-Lin Lee, further enhancing the impact of his research and innovations.

Conclusion

Kwang-Suk Lim's work in gene delivery systems represents a significant advancement in medical technology. His innovative patents and collaborations highlight his commitment to addressing critical health challenges.